Semaglutide Inducing Resolution of Proliferative Diabetic Retinopathy: A Case Report
2024

Semaglutide and Proliferative Diabetic Retinopathy

Sample size: 1 publication Evidence: low

Author Information

Author(s): Daniel Cool, James Coventon, Abhishek Sharma

Primary Institution: Princess Alexandra Hospital, Brisbane, Queensland, Australia

Hypothesis

Can semaglutide induce regression of proliferative diabetic retinopathy (PDR) independent of glycaemic control?

Conclusion

This case report suggests a potential independent role for semaglutide in managing PDR.

Supporting Evidence

  • Semaglutide therapy led to resolution of neovascularisation in the patient's right eye.
  • The patient showed improvement in diabetic macular oedema within 6 weeks of treatment.
  • Despite minimal changes in glycaemic control, the patient's eye condition improved significantly.

Takeaway

A woman with diabetic eye problems got better after taking a medicine called semaglutide, even though her blood sugar didn't change much.

Methodology

Case report.

Limitations

The findings are based on a single case and may not be generalizable.

Participant Demographics

47-year-old woman with Type 2 diabetes, obesity, hypertension, and dyslipidaemia.

Digital Object Identifier (DOI)

10.1155/crop/5834769

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication